RecruitingNot Applicable

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

Spain384 participantsStarted 2023-02-12

Plain-language summary

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.

Who can participate

Age range18 Years – 79 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed Crohn's disease or ulcerative colitis (at least 3 months before enrollment) * Male * Age from 18 to 79 years Exclusion Criteria: * Unclassified Inflammatory Bowel Disease * Diarrhea (\> 3 bowel movements/day) with rectal bleeding at enrollment * Prior full proctectomy * Inability to collect the biological samples * Inability to complete the questionnaire * Refusal to sign the informed consent

What they're measuring

Prevalence (number/percentage) of HPV infection in oral and anal samples

Timeframe: Up to 12 months

Prevalence (number/percentage) of abnormal HPV-related cytology in oral and anal samples

Timeframe: Up to 12 months

Trial details

NCT IDNCT05911750

SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-31

Contact for this trial

Antonio Giordano, MD

0034 932919000 dr.antoniogiordano@gmail.com

View on ClinicalTrials.gov More HPV Infection trials